Hyperglycemia and microvascular and macrovascular disease in diabetes - PubMed (original) (raw)
Review
Hyperglycemia and microvascular and macrovascular disease in diabetes
R Klein. Diabetes Care. 1995 Feb.
Abstract
In summary, over the past 16 years, since the publication of Kelly West's book, epidemiological study has provided better insight into the relation of hyperglycemia and diabetic complications. Data from the WESDR demonstrate a strong consistent relationship between hyperglycemia and the incidence and progression of microvascular (diabetic retinopathy, loss of vision, and nephropathy) and macrovascular (amputation and cardiovascular disease mortality) complications in people with IDDM and NIDDM (Figs. 19 and 20). The DCCT has demonstrated that intensive insulin therapy will reduce the incidence and progression of microvascular complications in people with IDDM (22). A number of further challenges await laboratory scientists and epidemiologists regarding hyperglycemia in people with diabetes. There is a need to understand the relation of hyperglycemia to pathogenetic mechanisms that lead to the development of specific complications, to develop new methods to detect and physiologically treat hyperglycemia, and to develop better methods of primary and secondary prevention of diabetic complications in people with IDDM and NIDDM.
Similar articles
- Relation of glycemic control to diabetic microvascular complications in diabetes mellitus.
Klein R, Klein BE, Moss SE. Klein R, et al. Ann Intern Med. 1996 Jan 1;124(1 Pt 2):90-6. doi: 10.7326/0003-4819-124-1_part_2-199601011-00003. Ann Intern Med. 1996. PMID: 8554220 - Blood glucose control and microvascular complications--what do we do now?
Dahl-Jørgensen K, Brinchmann-Hansen O, Bangstad HJ, Hanssen KF. Dahl-Jørgensen K, et al. Diabetologia. 1994 Dec;37(12):1172-7. doi: 10.1007/BF00399789. Diabetologia. 1994. PMID: 7895945 Review. No abstract available. - Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Ohkubo Y, et al. Diabetes Res Clin Pract. 1995 May;28(2):103-17. doi: 10.1016/0168-8227(95)01064-k. Diabetes Res Clin Pract. 1995. PMID: 7587918 Clinical Trial. - Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
Boel E, Selmer J, Flodgaard HJ, Jensen T. Boel E, et al. J Diabetes Complications. 1995 Apr-Jun;9(2):104-29. doi: 10.1016/1056-8727(94)00025-j. J Diabetes Complications. 1995. PMID: 7599349 Review.
Cited by
- Environmental Heavy Metal Exposure and Associated Cardiovascular Diseases in Light of the Triglyceride Glucose Index.
Sardar MB, Raza M, Fayyaz A, Nadir MA, Nadeem ZA, Babar M. Sardar MB, et al. Cardiovasc Toxicol. 2024 Aug 30. doi: 10.1007/s12012-024-09913-x. Online ahead of print. Cardiovasc Toxicol. 2024. PMID: 39212843 Review. - Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.
Kostopoulou E, Kalavrizioti D, Davoulou P, Sinopidis X, Papachristou E, Goumenos DS, Dimitriou G, Spiliotis BE, Papasotiriou M. Kostopoulou E, et al. Eur J Pediatr. 2024 May;183(5):2383-2389. doi: 10.1007/s00431-024-05496-5. Epub 2024 Mar 7. Eur J Pediatr. 2024. PMID: 38448612 - Nocturnal hypoglycemia is associated with next day cognitive performance in adults with type 1 diabetes: Pilot data from the GluCog study.
Zuniga-Kennedy M, Wang OH, Fonseca LM, Cleveland MJ, Bulger JD, Grinspoon E, Hansen D, Hawks ZW, Jung L, Singh S, Sliwinski M, Verdejo A, Miller KM, Weinstock RS, Germine L, Chaytor N. Zuniga-Kennedy M, et al. Clin Neuropsychol. 2024 Oct;38(7):1627-1646. doi: 10.1080/13854046.2024.2315749. Epub 2024 Feb 21. Clin Neuropsychol. 2024. PMID: 38380810 - A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression.
Oppler SH, Hocum Stone LL, Leishman DJ, Janecek JL, Moore MEG, Rangarajan P, Willenberg BJ, O'Brien TD, Modiano J, Pheil N, Dalton J, Dalton M, Ramachandran S, Graham ML. Oppler SH, et al. Sci Adv. 2024 Jan 5;10(1):eadi4919. doi: 10.1126/sciadv.adi4919. Epub 2024 Jan 5. Sci Adv. 2024. PMID: 38181083 Free PMC article. - Integrative bioinformatics analysis to screen key genes and signalling pathways related to ferroptosis in obesity.
Li MK, Xing C, Ma LQ. Li MK, et al. Adipocyte. 2023 Dec;12(1):2264442. doi: 10.1080/21623945.2023.2264442. Epub 2023 Oct 25. Adipocyte. 2023. PMID: 37878496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous